The session commenced with a warm welcome by Dr. J Suresh Department of Pharmacognosy, followed by an introduction to Dr. Nirmal Robinson’s expertise and contributions to the field. Dr. Robinson provided an in-depth exploration of metabolic vulnerabilities in glioblastoma, covering the following key aspects: • The metabolic landscape of glioblastoma and its role in tumour progression. • Key metabolic pathways exploited by glioblastoma cells for survival. • Potential therapeutic targets and novel treatment strategies. • The role of cellular stress in cancer metabolism. • Advances in immunotherapy and precision medicine for glioblastoma treatment. The lecture provided valuable insights into the molecular mechanisms underlying glioblastoma progression and the potential for targeted therapies to improve patient outcomes.